Posts In: Pharma

Global Response Aid, FujiFilm, Dr Reddy’s Partner on Potential COVID Drug

Global Response Aid and Dr. Reddy’s Laboratories have signed a deal with FujiFilm for global production and distribution of Avigan, an anti-viral drug being tested...

Dept of Consumer Affairs withdraws masks, hand sanitisers from Essential Commodities Act

The Department of Consumer Affairs, under the Ministry of Consumer Affairs, Food and Public Distribution, has taken off face masks and hand sanitisers from the...

“ In this movement I would like to appreciate your staff lady (Ms.Shruthi Harish, Accounts Receivable Dept.) who is communicating with our staff, her communication...

Piramal sells 20% in pharmaceutical business to Carlyle for $490 mn

A decade after the Piramal group sold its domestic formulations business to US-based Abbott for $3.72 billion, it has again signed a large deal to...

Pharma associations to make joint representation to govt over delay in custom clearance

The delay in customs clearance of China originated products is causing problems to the pharma industry. There is also a lot of confusion and ambiguity....

Dexamethasone for COVID-19: First Treatment to Reduce Risk of Death in Severely Ill Patients

The Corona virus and scientists are testing different drugs to control the pandemic. In a much welcome development, dexamethasone an easily obtainable, low-cost, common prescription...

Serum Institute of India to supply pneumonia vaccine to low-income nations

The Serum Institute of India will provide ten million doses of the pneumococcal conjugate vaccine, which helps to prevent severe pneumonia, every year to lower-income...

Roche rolls-out cluster strategy to cater to differing customer-needs

Expands partnership with Cipla, inks another with Entero Healthcare for cancer and nephrology products, respectively Roche Pharma is rolling out a new “cluster” strategy across...

Government to curb pharma imports from China

The government plans to tighten the regulatory noose around pharmaceuticals imports from China through stricter scrutiny of active pharmaceutical ingredients (APIs), key starting materials (KSMs)...